This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Response Genetics Inc (RGDX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 8.15M 9.04M 1.70M 4.12M
Receivables 6.23M 5.37M 4.05M 4.73M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 15.36M 14.99M 6.74M 9.80M
Property, Plant & Equipment, Gross 5.69M 4.28M 3.95M 3.43M
Accumulated Depreciation & Depletion 3.76M 3.26M 2.88M 2.62M
Property, Plant & Equipment, Net 1.93M 1.02M 1.07M 805.82K
Intangibles 767.22K 575.41K 44.42K 0.00
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 2.70M 1.60M 1.11M 805.82K
Liabilities & Shareholder Equity
Total Assets 18.06M 16.59M 7.85M 10.60M
Accounts Payable 1.69M 1.19M 1.49M 1.25M
Short Term Debt 157.24K 1.16M 1.15M 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 5.66M 5.27M 5.89M 5.92M
Long Term Debt 1.00M 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 5.50M 11.78M 7.85M 7.95M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 6.64M 11.86M 8.10M 7.95M
Total Liabilities 12.30M 17.13M 13.99M 13.88M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 5.76M -542.21K -6.14M -3.28M
Common Par 337.18K 232.41K 134.33K 122.94K
Additional Paid In Capital 70.99M 56.77M 43.51M 40.61M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -65.30M -57.28M -49.52M -43.82M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -267.46K -264.00K -267.18K -193.96K
Total Capitalization 6.76M -542.21K -6.14M -3.28M
Total Equity 5.76M -542.21K -6.14M -3.28M
Total Liabilities & Stock Equity 18.06M 16.59M 7.85M 10.60M
Total Common Shares Outstanding 38.71M 32.80M 19.54M 18.36M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 33.48M 26.74M 19.12M 17.79M
Diluted Weighted Shares Outstanding 33.48M 26.74M 19.12M 17.79M
Number of Employees 109 90 100 87
Number of Part-Time Employees 4 9 5 8

RGDX Response Genetics Inc

Analysts Ratings for RGDX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

RGDX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs